Cannoni M, Pellet W, Pech A, Zanaret M, Thomassin J M, Abram D, Emram B, Derome P, Cannoni C
Département d'ORL et de Chirurgie Cervico-Faciale, CHRU, Hôpital d'Adultes de la Timone, Marseille.
Ann Otolaryngol Chir Cervicofac. 1993;110(1):18-28.
The authors report their experience using an enlarged middle cranial fossa approach for the removal of 33 acoustic neurinomas and 10 cerebellopontine angle meningiomas. The Technique is defined. This approach proved suitable for stage I neurinomas, ensuring total removal in all 13 patients with stage I lesions, hearing conservation in 9 (69.2%) of these patients, grade 1 + 2 facial nerve function in 80% of patients and grade 3 function in 20% of patients. While total removal was always possible for stage II neurinomas, the functional results were poor with hearing conservation in only 3 of 15 patients (20%), grade 1 + 2 facial nerve function in 45% of patients and grade 3 function in 54% of patients. Total removal was possible in only 1 of 4 patients with stage III neurinomas. This approach proved excellent for cerebellopontine anale meningiomas, providing wide access to the tumor and protecting the acoustico-facial bundle situated behind the tumor. Among the 10 patients operated by this route, 8 had conservation of hearing and all 10 had normal facial motricity (grade I) at 3 months.
作者报告了他们使用扩大中颅窝入路切除33例听神经瘤和10例桥小脑角脑膜瘤的经验。对该技术进行了定义。该入路被证明适用于I期听神经瘤,13例I期病变患者均实现全切,其中9例(69.2%)患者听力得以保留,80%的患者面神经功能为1+2级,20%的患者为3级。对于II期听神经瘤,虽然全切总是可行的,但功能结果较差,15例患者中只有3例(20%)听力得以保留,45%的患者面神经功能为1+2级,54%的患者为3级。4例III期听神经瘤患者中只有1例能够全切。该入路被证明对桥小脑角脑膜瘤非常有效,能够广泛暴露肿瘤并保护位于肿瘤后方的听神经和面神经束。通过该入路手术的10例患者中,8例听力得以保留,所有10例患者在3个月时面部运动功能均正常(I级)。